Pinar Topsever comments on the TriMaster study of a stratified medicine approach to second- and third-line treatment for type 2 diabetes, and discusses what the results mean for primary care practice (10:04).
00:00 Take-home messages
04:43 Other stratification factors
06:05 Limitations and future directions for research